TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|||
1. Identity of the issuer or the underlying issuer |
Tissue Regenix Group plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
X |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
IP Group plc |
|||
4. Full name of shareholder(s) |
See section 9 |
|||
5. Date of the transaction and date on |
19 May 2015 |
|||
6. Date on which issuer notified: |
20 May 2015 |
|||
7. Threshold(s) that is/are crossed or |
Direct interests: unchanged Indirect interests: Below 3% Combined direct and indirect interests: 14% reached
|
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct xi |
Indirect xii |
Direct |
Indirect |
|||||||||||||
Ordinary 0.5p Shares |
127,837,566 |
127,837,566 |
110,837,566
|
103,042,836 |
7,794,730 |
13.56% |
1.03% |
|||||||||
GB00B5SGVL29 |
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
110,837,566
|
14.59% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||||||||||||||||
Direct interests:
Techtran Group Limited - 103,042,836
Techtran Group Limited is a 100% owned subsidiary of IP Group plc.
Indirect interests:
IP Venture Fund - 7,794,730
IP Venture Fund is a limited partnership fund that is managed by Top Technology Ventures Limited, a 100% subsidiary of IP Group plc.
|
||||||||||||||||
|
||||||||||||||||
Proxy Voting: |
||||||||||||||||
10. Name of the proxy holder: |
|
|||||||||||||||
11. Number of voting rights proxy holder will cease |
|
|||||||||||||||
12. Date on which proxy holder will cease to hold |
|
|||||||||||||||
|
||||||||||||||||
13. Additional information: |
This notification relates to reductions in the holdings in the issuer by IP Venture Fund. IP Group's direct holdings are unchanged.
Based on 759,653,093 Ordinary Shares in issue |
|||||||||||||||
14. Contact name: |
Greg Smith |
|||||||||||||||
15. Contact telephone number: |
020 7444 0050 |
|||||||||||||||